Timing of antiretroviral therapy for HIV in the setting of TB treatment

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Karakousis, Petros C ^a,b   Piggott, Damani A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STAVUDINE; STREPTOMYCIN; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TUBERCULOSTATIC AGENT;

ANEMIA; ANTIBIOTIC THERAPY; DIZZINESS; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LIVER TOXICITY; MIXED INFECTION; MORBIDITY; MORTALITY; PANDEMIC; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; AIDS RELATED COMPLEX; CLINICAL TRIAL (TOPIC); DRUG ADMINISTRATION; DRUG EFFECT; DRUG INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HIV INFECTIONS; HIV-1; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 79952222721     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/103917     Document Type: Review

References (89)

1. UNAIDS, Joint United Nations Program on HIV/AIDS, 2008 Report on the global AIDS epidemic. http://data.unaids.org/pub/GlobalReport/2008/ JC1511GR08ExecutiveSummaryen.pdf
2. World Health Organization, Global Tuberculosis Control 2009. World Health Organization, Geneva, Switzerland, 2009, http://whqlibdoc.who.int/publications/ 2009/9789241563802eng.pdf
3. Swaminathan S., Rekha B., Pediatric tuberculosis: global overview and challenges Clinical Infectious Diseases 2010 50 supplement 3 S184 S194
4. Getahun H., Gunneberg C., Granich R., Nunn P., HIV infection-associated tuberculosis: the epidemiology and the response Clinical Infectious Diseases 2010 50 supplement 3 S201 S207
5. Corbett E. L., Watt C. J., Walker N., Maher D., Williams B. G., Raviglione M. C., Dye C., The growing burden of tuberculosis: global trends and interactio (Pubitemid 36548927)
6. Lpez-Gatell H., Cole S. R., Hessol N. A., French A. L., Greenblatt R. M., Landesman S., Preston-Martin S., Anastos K., Effect of tuberculosis on the survival of women infected with human immunodeficiency virus American Journal of Epidemiology 2007 165 10 1134 1142 (Pubitemid 47233709)
7. World Health Organization, Anti-tuberculosis drug resistance in the world: fourth global report. World Health Organization, Geneva, Switzerland, 2008, http://whqlibdoc.who.int/hq/2008/WHOHTMTB2008.394eng.pdf
8. Wells C. D., Cegielski J. P., Nelson L. J., Laserson K. F., Holtz T. H., Finlay A., Castro K. G., Weyer K., HIV infection and multidrug-resistant tuberculosisthe perfect storm Journal of Infectious Diseases 2007 196 supplement 1 S86 S107
9. Gandhi N. R., Moll A., Sturm A. W., Pawinski R., Govender T., Lalloo U., Zeller K., Andrews J., Friedland G., Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa The Lancet 2006 368 9547 1575 1580 (Pubitemid 44780738)
10. Cooper A. M., Cell-mediated immune responses in tuberculosis Annual Review of Immunology 2009 27 393 422
11. Harding C. V., Boom W. H., Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors Nature Reviews Microbiology 2010 8 4 296 307
12. Sharma S. K., Mohan A., Sharma A., Mitra D. K., Miliary tuberculosis: new insights into an old disease The Lancet Infectious Diseases 2005 5 7 415 430 (Pubitemid 40840733)
13. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H., A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection The New England Journal of Medicine 1989 320 9 545 550 (Pubitemid 19070537)
14. Antonucci G., Girardi E., Raviglione M. C., Ippolito G., Risk factors for tuberculosis in HIV-infected persons: a prospective cohort study Journal of the American Medical Association 1995 274 2 143 148
15. Markowitz N., Hansen N. I., Hopewell P. C., Glassroth J., Kvale P. A., Mangura B. T., Wilcosky T. C., Wallace J. M., Rosen M. J., Lee Reichman B., Incidence of tuberculosis in the United States among HIV-infected persons Annals of Internal Medicine 1997 126 2 123 132 (Pubitemid 27058586)
16. Moreno S., Baraia-Etxaburu J., Bouza E., Parras F., Perez-Tascon M., Miralles P., Vicente T., Alberdi J. C., Cosin J., Lopez-Gay D., Risk for developing tuberculosis among anergic patients infected with HIV Annals of Internal Medicine 1993 119 3 194 198 (Pubitemid 23327618)
17. Bucher H. C., Griffith L. E., Guyatt G. H., Sudre P., Naef M., Sendi P., Battegay M., Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials AIDS 1999 13 4 501 507
18. Wilkinson D., Squire S. B., Garner P., Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials British Medical Journal 1998 317 7159 625 629 (Pubitemid 28403484)
19. Woldehanna S., Volmink J., Treatment of latent tuberculosis infection in HIV infected persons Cochrane Database of Systematic Reviews 2010 1
20. Badri M., Wilson D., Wood R., Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study The Lancet 2002 359 9323 2059 2064 (Pubitemid 34680968)
21. Girardi E., Sabin C. A., Monferte A. D., Hogg B., Phillips A. N., Gill M. J., Dabis F., Reiss P., Kirk O., Bemasconi E., Grabar S., Justice A., Staszewski S., Ftkenheuer G., Sterne J. A. C., Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Clinical Infectious Diseases 2005 41 12 1772 1782 (Pubitemid 41759864)
22. Santoro-Lopes G., De Pinho A. M. F., Harrison L. H., Schechter M., Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy Clinical Infectious Diseases 2002 34 4 543 546 (Pubitemid 34112278)
23. Lawn S. D., Myer L., Bekker L.-G., Wood R., Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control AIDS 2006 20 12 1605 1612 (Pubitemid 44162402)
24. Hopewell P. C., Pai M., Maher D., Uplekar M., Raviglione M. C., International standards for Tuberculosis care The Lancet Infectious Diseases 2006 6 11 710 725 (Pubitemid 44740086)
25. Fitzgerald D. W., Desvarieux M., Severe P., Joseph P., Johnson W. D. Jr., Pape J. W., Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial The Lancet 2000 356 9240 1470 1474
26. Perriens J. H., St. Louis M. E., Mukadi Y. B., Brown C., Prignot J., Pouthier F., Portaels F., Willame J.-C., Mandala J. K., Kaboto M., Ryder R. W., Roscigno G., Piot P., Pulmonary tuberculosis in HIV-infected patients in Zairea controlled trial of treatment for either 6 or 12 months The New England Journal of Medicine 1995 332 12 779 784
27. Khan F. A., Minion J., Pai M., Royce S., Burman W., Harries A. D., Menzies D., Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis Clinical Infectious Diseases 2010 50 9 1288 1299
28. Lutfey M., Della-Latta P., Kapur V., Palumbo L. A., Gurner D., Stotzky G., Brudney K., Dobkin J., Moss A., Musser J. M., Kreiswirth B. N., Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS American Journal of Respiratory and Critical Care Medicine 1996 153 2 837 840 (Pubitemid 26051369)
29. Nolan C. M., Williams D. L., Cave M. D., Eisenach K. D., El-Hajj H., Hooton T. M., Thompson R. L., Goldberg S. V., Evolution of rifampin resistance in human immunodeficiency virus- associated tuberculosis American Journal of Respiratory and Critical Care Medicine 1995 152 3 1067 1071
30. Burman W. J., Jones B. E., Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy American Journal of Respiratory and Critical Care Medicine 2001 164 1 7 12 (Pubitemid 33151292)
31. Dean G. L., Edwards S. G., Ives N. J., Matthews G., Fox E. F., Navaratne L., Fisher M., Taylor G. P., Miller R., Taylor C. B., De Ruiter A., Pozniak A. L., Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy AIDS 2002 16 1 75 83 (Pubitemid 34062184)
32. Sterling T. R., Pham P. A., Chaisson R. E., HIV infection-related tuberculosis: clinical manifestations and treatment Clinical Infectious Diseases 2010 50 supplement 3 S223 S230
33. Boulle A., Van Cutsem G., Cohen K., Hilderbrand K., Mathee S., Abrahams M., Goemaere E., Coetzee D., Maartens G., Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy Journal of the American Medical Association 2008 300 5 530 539
34. Manosuthi W., Sungkanuparph S., Tantanathip P., Lueangniyomkul A., Mankatitham W., Prasithsirskul W., Burapatarawong S., Thongyen S., Likanonsakul S., Thawornwa U., Prommool V., Ruxrungtham K., A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in hiv-infected patients receiving rifampicin: the N2R study Clinical Infectious Diseases 2009 48 12 1752 1759
35. French M. A., Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy Current HIV/AIDS Reports 2007 4 1 16 21 (Pubitemid 46555247)
36. Meintjes G., Lynen L., Prevention and treatment of the immune reconstitution inflammatory syndrome Current Opinion in HIV and AIDS 2008 3 4 468 476
37. Puthanakit T., Aurpibul L., Oberdorfer P., Akarathum N., Kanjananit S., Wannarit P., Sirisanthana T., Sirisanthana V., Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy Clinical Infectious Diseases 2007 44 4 599 604 (Pubitemid 46233267)
38. Grant P. M., Komarow L., Andersen J., Sereti I., Pahwa S., Lederman M. M., Eron J., Sanne I., Powderly W., Hogg E., Suckow C., Zolopa A., Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection PLoS ONE 2010 5 7 1 7
39. Manabe Y. C., Campbell J. D., Sydnor E., Moore R. D., Immune reconstitution inflammatory syndrome: risk factors and treatment implications Journal of Acquired Immune Deficiency Syndromes 2007 46 4 456 462 (Pubitemid 350098697)
40. Murdoch D. M., Venter W. D. F., Feldman C., Van Rie A., Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study AIDS 2008 22 5 601 610 (Pubitemid 351640593)
41. Shelburne S. A., Visnegarwala F., Darcourt J., Graviss E. A., Giordano T. P., White A. C. Jr., Hamill R. J., Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy AIDS 2005 19 4 399 406 (Pubitemid 40446186)
42. Breen R. A. M., Smith C. J., Bettinson H., Dart S., Bannister B., Johnson M. A., Lipman M. C. I., Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection Thorax 2004 59 8 704 707 (Pubitemid 39061536)
43. Crump J. A., Tyrer M. J., Lloyd-Owen S. J., Han L. Y., Lipman M. C., Johnson M. A., Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy Clinical Infectious Diseases 1998 26 4 1008 1009 (Pubitemid 28180357)
44. Hung C.-C., Chen M.-Y., Hsiao C.-F., Hsieh S.-M., Sheng W.-H., Chang S.-C., Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy AIDS 2003 17 18 2615 2622 (Pubitemid 38402339)
45. Lawn S. D., Bekker L.-G., Miller R. F., Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals The Lancet Infectious Diseases 2005 5 6 361 373 (Pubitemid 40779257)
46. Meintjes G., Rabie H., Wilkinson R. J., Cotton M. F., Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy Clinics in Chest Medicine 2009 30 4 797 810
47. Navas E., Martn-Dvila P., Moreno L., Pintado V., Casado J. L., Fortn J., Prez-Elas M. J., Gomez-Mampaso E., Moreno S., Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy Archives of Internal Medicine 2002 162 1 97 99 (Pubitemid 34073410)
48. Valin N., Pacanowski J., Denoeud L., Lacombe K., Lalande V., Fonquernie L., Girard P.-M., Meynard J.-L., Risk factors for unmasking immune reconstitution inflammatory syndrome presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients AIDS 2010 24 10 1519 1525
49. Zolopa A. R., Andersen J., Komarow L., Sanne I., Sanchez A., Hogg E., Suckow C., Powderly W., Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial PLoS ONE 2009 4 5
50. Lawn S. D., Harries A. D., Anglaret X., Myer L., Wood R., Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa AIDS 2008 22 15 1897 1908
51. Leonard M. K., Larsen N., Drechsler H., Blumberg H., Lennox J. L., Arrellano M., Filip J., Horsburgh C. R. Jr., Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 19912000 Clinical Infectious Diseases 2002 34 7 1002 1007 (Pubitemid 34229770)
52. Sungkanuparph S., Manosuthi W., Kiertiburanakul S., Vibhagool A., Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand Journal of Infection 2006 52 3 188 194 (Pubitemid 43286185)
53. Manosuthi W., Chottanapand S., Thongyen S., Chaovavanich A., Sungkanuparph S., Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 2006 43 1 42 46 (Pubitemid 44306486)
54. Sanguanwongse N., Cain K. P., Suriya P., Nateniyom S., Yamada N., Wattanaamornkiat W., Sumnapan S., Sattayawuthipong W., Kaewsa-Ard S., Ingkaseth S., Varma J. K., Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand Journal of Acquired Immune Deficiency Syndromes 2008 48 2 181 189
55. Tabarsi P., Saber-Tehrani A. S., Baghaei P., Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV Journal of the International AIDS Society 2009 12 1 14
56. Velasco M., Castilla V., Sanz J., Gaspar G., Condes E., Barros C., Cervero M., Torres R., Guijarro C., Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis Journal of Acquired Immune Deficiency Syndromes 2009 50 2 148 152
57. Torok M. E., Yen N. T. B., Chau T. T. H., Randomised controlled trial of immediate versus deferred antiretroviral therapy in HIV-associated tuberculosis meningitis Proceedings of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy 2009 San Francisco, Calif, USA
58. Abdool Karim S. S., Naidoo K., Grobler A., Padayatchi N., Baxter C., Gray A., Gengiah T., Nair G., Bamber S., Singh A., Khan M., Pienaar J., El-Sadr W., Friedland G., Abdool Karim Q., Timing of initiation of antiretroviral drugs during tuberculosis therapy The New England Journal of Medicine 2010 362 8 697 706
59. Blanc F. X., Sok T., Laureillard D., Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis Proceedings of the 16th International AIDS Society Conference 2010 Vienna, Austria
60. Blanc F.-X., Havlir D. V., Onyebujoh P. C., Thim S., Goldfeld A. E., Delfraissy J.-F., Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials Journal of Infectious Diseases 2007 196 supplement 1 S46 S51
61. ACTG A5221, Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis. http://clinicaltrials.gov/ct2/ show/NCT00108862
62. World Health Organization, Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. World Health Organization, Geneva, Switzerland, 2010, http://whqlibdoc.who.int/publications/2010/9789241599764eng.pdf
63. Burman W., Weis S., Vernon A., Khan A., Benator D., Jones B., Silva C., King B., LaHart C., Mangura B., Weiner M., El-Sadr W., Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis International Journal of Tuberculosis and Lung Disease 2007 11 12 1282 1289
64. Kumarasamy N., Chaguturu S., Mayer K. H., Solomon S., Yepthomi H. T., Balakrishnan P., Flanigan T. P., Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India Journal of Acquired Immune Deficiency Syndromes 2004 37 5 1574 1576 (Pubitemid 39658195)
65. Lawn S. D., Myer L., Bekker L.-G., Wood R., Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa AIDS 2007 21 3 335 341 (Pubitemid 46175045)
66. Narita M., Ashkin D., Hollender E. S., Pitchenik A. E., Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with aids American Journal of Respiratory and Critical Care Medicine 1998 158 1 157 161 (Pubitemid 28337174)
67. Schiffer J. T., Sterling T. R., Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis Journal of Acquired Immune Deficiency Syndromes 2007 44 2 229 234 (Pubitemid 46292227)
68. Meintjes G., Lawn S. D., Scano F., Maartens G., French M. A., Worodria W., Elliott J. H., Murdoch D., Wilkinson R. J., Seyler C., John L., van der Loeff M. S., Reiss P., Lynen L., Janoff E. N., Gilks C., Colebunders R., Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings The Lancet Infectious Diseases 2008 8 8 516 523 (Pubitemid 352005824)
69. McCombe J. A., Auer R. N., Maingat F. G., Houston S., Gill M. J., Power C., Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology Neurology 2009 72 9 835 841
70. Johnson T., Nath A., Neurological complications of immune reconstitution in HIV-infected populations Annals of the New York Academy of Sciences 2010 1184 106 120
71. Pepper D. J., Marais S., Maartens G., Rebe K., Morroni C., Rangaka M. X., Oni T., Wilkinson R. J., Meintjes G., Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series Clinical Infectious Diseases 2009 48 11 e96 e107
72. Kambugu A., Meya D. B., Rhein J., O'Brien M., Janoff E. N., Ronald A. R., Kamya M. R., Mayanja-Kizza H., Sande M. A., Bohjanen P. R., Boulware D. R., Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy Clinical Infectious Diseases 2008 46 11 1694 1701 (Pubitemid 351706766)
73. Lawn S. D., Bekker L.-G., Myer L., Orrell C., Wood R., Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme AIDS 2005 19 17 2050 2052 (Pubitemid 41669038)
74. Makadzange A. T., Ndhlovu C. E., Takarinda K., Reid M., Kurangwa M., Gona P., Hakim J. G., Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa Clinical Infectious Diseases 2010 50 11 1532 1538
75. Dautremer J., Pacanowski J., Girard P.-M., Lalande V., Sivignon F., Meynard J.-L., A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis AIDS 2007 21 3 381 382 (Pubitemid 46175055)
76. Lee C.-H., Lui C.-C., Liu J.-W., Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma AIDS Patient Care and STDs 2007 21 4 234 239 (Pubitemid 46676677)
77. Ramdas K., Minamoto G. Y., Paradoxical presentation of intracranial tuberculomas after chemotherapy in a patient with AIDS Clinical Infectious Diseases 1994 19 4 793 794 (Pubitemid 24301166)
78. Newton S. M., Brent A. J., Anderson S., Whittaker E., Kampmann B., Paediatric tuberculosis The Lancet Infectious Diseases 2008 8 8 498 510 (Pubitemid 352001412)
79. World Health Organization, Antiretroviral Therapy of HIV Infection in Infants and Children: Towards Universal Access-Recommendations for a Public Health Approach: 2010 Revision. World Health Organization, Geneva, Switzerland, 2010, http://whqlibdoc.who.int/publications/2010/9789241599801eng.pdf
80. Yotebieng M., Van Rie A., Moultrie H., Cole S. R., Adimora A., Behets F., Meyers T., Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment AIDS 2010 24 9 1341 1349
81. Sungkanuparph S., Eampokalap B., Chottanapund S., Thongyen S., Manosuthi W., Impact of drug-resistant tuberculosis on the survival of HIV-infected patients International Journal of Tuberculosis and Lung Disease 2007 11 3 325 330 (Pubitemid 46447442)
82. Shenoi S., Heysell S., Moll A., Friedland G., Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community Current Opinion in Infectious Diseases 2009 22 1 11 17
83. Migliori G. B., Dheda K., Centis R., Mwaba P., Bates M., O'Grady J., Hoelscher M., Zumla A., Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa Tropical Medicine and International Health 2010 15 9 1052 1066
84. Bonora S., Di Perri G., Interactions between antiretroviral agents and those used to treat tuberculosis Current Opinion in HIV and AIDS 2008 3 3 306 312 (Pubitemid 351521015)
85. Kitahata M. M., Gange S. J., Abraham A. G., Merriman B., Saag M. S., Justice A. C., Hogg R. S., Deeks S. G., Eron J. J., Brooks J. T., Rourke S. B., Gill M. J., Bosch R. J., Martin J. N., Klein M. B., Jacobson L. P., Rodriguez B., Sterling T. R., Kirk G. D., Napravnik S., Rachlis A. R., Calzavara L. M., Horberg M. A., Silverberg M. J., Gebo K. A., Goedert J. J., Benson C. A., Collier A. C., Van Rompaey S. E., Crane H. M., McKaig R. G., Lau B., Freeman A. M., Moore R. D., Effect of early versus deferred antiretroviral therapy for HIV on survival The New England Journal of Medicine 2009 360 18 1815 1826
86. Sterne J. A., May M., Costagliola D., Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies The Lancet 2009 373 9672 1352 1363
87. Walensky R. P., Wolf L. L., Wood R., Fofana M. O., Freedberg K. A., Martinson N. A., Paltiel A. D., Anglaret X., Weinstein M. C., Losina E., When to start antiretroviral therapy in resource-limited settings Annals of Internal Medicine 2009 151 3 157 166
88. Thompson M. A., Aberg J. A., Cahn P., Montaner J. S.G., Rizzardini G., Telenti A., Gatell J. M., Gnthard H. F., Hammer S. M., Hirsch M. S., Jacobsen D. M., Reiss P., Richman D. D., Volberding P. A., Yeni P., Schooley R. T., Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel Journal of the American Medical Association 2010 304 3 321 333
89. World Health Organization, Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. World Health Organization, Geneva, Switzerland, 2008, http://www.who.int/hiv/pub/tuapr2009en.pd